
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.670 | 2.670 | 0.000 |
Shares | 97.210 | 97.210 | 0.000 |
Other | 0.120 | 0.130 | 0.010 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.593 | 23.606 |
Price to Book | 3.698 | 4.558 |
Price to Sales | 2.860 | 3.518 |
Price to Cash Flow | 14.808 | 15.605 |
Dividend Yield | 1.521 | 1.301 |
5 Years Earnings Growth | 11.496 | 10.722 |
Name | Net % | Category Average |
---|---|---|
Technology | 24.040 | 27.791 |
Healthcare | 14.540 | 14.050 |
Consumer Cyclical | 14.500 | 12.459 |
Financial Services | 12.380 | 15.091 |
Industrials | 12.120 | 12.427 |
Communication Services | 11.210 | 9.049 |
Consumer Defensive | 3.970 | 6.144 |
Basic Materials | 3.550 | 3.792 |
Energy | 2.310 | 2.514 |
Utilities | 0.950 | 2.391 |
Real Estate | 0.430 | 1.676 |
Number of long holdings: 256
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.77 | 719.17 | -2.56% | |
Broadcom | US11135F1012 | 3.50 | 264.77 | -3.95% | |
Microsoft | US5949181045 | 3.38 | 492.05 | -1.08% | |
Taiwan Semicon | TW0002330008 | 3.29 | 1,060.00 | -1.85% | |
Tesla | US88160R1014 | 3.19 | 300.71 | -5.34% | |
NVIDIA | US67066G1040 | 2.37 | 153.29 | -2.97% | |
Novo Nordisk B | DK0062498333 | 1.91 | 438.4 | -0.30% | |
Netflix | US64110L1061 | 1.60 | 1,293.21 | -3.43% | |
Amazon.com | US0231351067 | 1.50 | 220.45 | +0.48% | |
Eli Lilly | US5324571083 | 1.39 | 775.90 | -0.47% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CapGroup NewPerspectiveLux Cadh AUD | 17.63B | 19.02 | 2.98 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review